Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 34.17M | $30.0M | 11.59% | -- | 2026-06-30 |
| BVF INC/IL | 28.16M | $24.0M | 9.56% | +8.64M | 2026-06-30 |
| MAVERICK CAPITAL LTD | 18.97M | $16.0M | 6.44% | -- | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 18.49M | $16.0M | 6.27% | -2.37M | 2026-06-30 |
| BlackRock, Inc. | 16.13M | $14.0M | 5.47% | +11.85M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.50M | $9.0M | 3.56% | +422.2K | 2026-06-30 |
| M28 Capital Management LP | 9.25M | $8.0M | 3.14% | -- | 2026-06-30 |
| Saturn V Capital Management LP | 8.39M | $7.0M | 2.85% | -2.56M | 2026-06-30 |
| Soleus Capital Management, L.P. | 7.71M | $6.0M | 2.62% | -- | 2026-06-30 |
| Point72 Asset Management, L.P. | 7.54M | $6.0M | 2.56% | +7.50M | 2026-06-30 |
